{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:54:12Z","timestamp":1765961652624},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clinical experts experienced challenges in the practice of palliative sedation (PS) during the COVID-19 pandemic. Rapid deterioration in patients\u2019 situation was observed while the indications for starting PS seemed to differ compared to other terminal patients. It is unclear to which extent clinical trajectories of PS differ for these COVID patients compared to regular clinical practice of PS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To describe the clinical practice of PS in patients with COVID versus non-COVID patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of data from a Dutch tertiary medical centre was performed. Charts of adult patients who died with PS during hospitalisation between March \u201920 and January \u201821 were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period, 73 patients received PS and of those 25 (34%) had a COVID infection. Refractory dyspnoea was reported as primary indication for starting PS in 84% of patients with COVID compared to 33% in the other group (p\u2009&lt;\u20090.001). Median duration of PS was significantly shorter in the COVID group (5.8 vs. 17.1\u00a0h, p\u2009&lt;\u20090.01). No differences were found for starting dosages, but median hourly dose of midazolam was higher in the COVID group (4.2\u00a0mg\/hr vs. 2.4\u00a0mg\/hr, p\u2009&lt;\u20090.001). Time interval between start PS and first medication adjustments seemed to be shorter in COVID patients (1.5 vs. 2.9\u00a0h, p\u2009=\u20090.08).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PS in COVID patients is characterized by rapid clinical deterioration in all phases of the trajectory. What is manifested by earlier dose adjustments and higher hourly doses of midazolam. Timely evaluation of efficacy is recommended in those patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-023-01156-x","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:02:22Z","timestamp":1680573742000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical practice of palliative sedation in patients dying from COVID-19: a retrospective chart review"],"prefix":"10.1186","volume":"22","author":[{"given":"Maaike","family":"Rijpstra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Kuip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Hasselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2147\/JMDH.S357867","volume":"15","author":"A Talukder","year":"2022","unstructured":"Talukder A, Razu SR, Alif SM, Rahman MA, Islam SMS. Association between symptoms and severity of Disease in Hospitalised Novel Coronavirus (COVID-19) patients: a systematic review and Meta-analysis. J Multidiscip Healthc. 2022;15:1101\u201310.","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"1156_CR2","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jpainsymman.2020.04.015","volume":"60","author":"N Lovell","year":"2020","unstructured":"Lovell N, Maddocks M, Etkind SN, et al. Characteristics, Symptom Management, and outcomes of 101 patients with COVID-19 referred for Hospital Palliative Care. J Pain Symptom Manage. 2020;60(1):e77\u2013e81.","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"1156_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0269216320947312","volume":"34","author":"B Alderman","year":"2020","unstructured":"Alderman B, Webber K, Davies A. An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliat Med. 2020;34(9):1249\u201355.","journal-title":"Palliat Med"},{"issue":"7","key":"1156_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0269216309107024","volume":"23","author":"NI Cherny","year":"2009","unstructured":"Cherny NI, Radbruch L, Board of the European Association for Palliative C. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23(7):581\u201393.","journal-title":"Palliat Med"},{"key":"1156_CR5","unstructured":"Hasselaar J, Vissers K, Mercadante S et al. Palliative sedation in the context of COVID-19: Expert opinions from the Palliative Sedation project. EAPC. 2020: https:\/\/eapcnet.wordpress.com\/2020\/04\/20\/palliative-sedation-in-the-context-of-covid-19-expert-opinions-from-the-palliative-sedation-project\/."},{"issue":"10","key":"1156_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0269216313486952","volume":"27","author":"NJ Preston","year":"2013","unstructured":"Preston NJ, Fayers P, Walters SJ, et al. Recommendations for managing missing data, attrition and response shift in palliative and end-of-life care research: part of the MORECare research method guidance on statistical issues. Palliat Med. 2013;27(10):899\u2013907.","journal-title":"Palliat Med"},{"issue":"9","key":"1156_CR7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1177\/0269216320949786","volume":"34","author":"L Hetherington","year":"2020","unstructured":"Hetherington L, Johnston B, Kotronoulas G, et al. COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care. Palliat Med. 2020;34(9):1256\u201362.","journal-title":"Palliat Med"},{"key":"1156_CR8","doi-asserted-by":"crossref","unstructured":"Ramos-Rincon JM, Moreno-Perez O, Gomez-Martinez N et al. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study Medicina (Kaunas). 2021;57(9).","DOI":"10.3390\/medicina57090873"},{"issue":"1","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/jpm.2021.0049","volume":"25","author":"S Golob","year":"2022","unstructured":"Golob S, Zilinyi R, Godfrey S, et al. The prevalence of Palliative Care Consultation in deceased COVID-19 patients and its association with end-of-Life Care. J Palliat Med. 2022;25(1):70\u20134.","journal-title":"J Palliat Med"},{"issue":"4","key":"1156_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpainsymman.2020.09.022","volume":"61","author":"M Arantzamendi","year":"2021","unstructured":"Arantzamendi M, Belar A, Payne S, et al. Clinical aspects of Palliative Sedation in prospective studies. A systematic review. J Pain Symptom Manage. 2021;61(4):831\u201344. e10.","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"1156_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/thoraxjnl-2020-216001","volume":"76","author":"J Berenguer","year":"2021","unstructured":"Berenguer J, Borobia AM, Ryan P, et al. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax. 2021;76(9):920\u20139.","journal-title":"Thorax"},{"issue":"1","key":"1156_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1089\/pmr.2021.0010","volume":"2","author":"H Okabayashi","year":"2021","unstructured":"Okabayashi H, Kitamura H, Ikeda S, et al. Patients with terminal interstitial pneumonia require comparable or more palliative pharmacotherapy for refractory dyspnea than patients with terminal Lung Cancer. Palliat Med Rep. 2021;2(1):188\u201393.","journal-title":"Palliat Med Rep"},{"key":"1156_CR13","unstructured":"ten Cate M, Brink A, Struik L, Thijs-Visser M. Palliative Sedation for COVID 19 patients can be improved [article in Dutch]. Medisch Contact. 2021: https:\/\/www.medischcontact.nl\/nieuws\/laatste-nieuws\/artikel\/palliatieve-sedatie-voor-covid-19-patienten-kan-veel-beter.html"},{"issue":"9","key":"1156_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1089\/jpm.2018.0372","volume":"22","author":"A Abdul-Razzak","year":"2019","unstructured":"Abdul-Razzak A, Lemieux L, Snyman M, Perez G, Sinnarajah A. Description of continuous Palliative Sedation Practices in a large Health Region and Comparison with Clinical Practice Guidelines. J Palliat Med. 2019;22(9):1052.","journal-title":"J Palliat Med"},{"key":"1156_CR15","doi-asserted-by":"publisher","unstructured":"Abstracts from the 17th World Congress of the EAPC 2021. Palliative Medicine. 2021;35(1_suppl):1-243, abstract number: R-53, https:\/\/doi.org\/10.1177\/02692163211035909DOI","DOI":"10.1177\/02692163211035909"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-023-01156-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:03:11Z","timestamp":1680573791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-023-01156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/s12904-023-01156-x","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed by the Research Ethics Committee (REC) of the Radboud University Medical Centre in Nijmegen (2020\/6663). The REC of the Radboud University Medical Centre in Nijmegen waived the need of ethical approval and informed consent, as all data were provided by the database retrospectively.All methods were carried out in accordance with relevant guidelines and applicable regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}